Clinical Trial Update: Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial comparing GNR-038 to Berinert for hereditary angioedema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Berinert (C1 esterase inhibitor)
• GNR-038

Snippet

Sponsor: AO GENERIUM | Conditions: Hereditary Angioedema | Phase 2, Phase 3 | Status: WITHDRAWN